Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) EPS (Basic) (2016 - 2025)

Anaptysbio (ANAB) has disclosed EPS (Basic) for 10 consecutive years, with $1.62 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Basic) rose 345.45% year-over-year to $1.62, compared with a TTM value of -$0.46 through Dec 2025, up 91.07%, and an annual FY2025 reading of -$0.46, up 91.02% over the prior year.
  • EPS (Basic) was $1.62 for Q4 2025 at Anaptysbio, up from $0.54 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $1.62 in Q4 2025 and bottomed at -$1.71 in Q2 2024.
  • Average EPS (Basic) over 5 years is -$0.92, with a median of -$1.18 recorded in 2021.
  • The sharpest move saw EPS (Basic) plummeted 5650.0% in 2022, then skyrocketed 345.45% in 2025.
  • Year by year, EPS (Basic) stood at -$1.19 in 2021, then grew by 21.85% to -$0.93 in 2022, then plummeted by 70.97% to -$1.59 in 2023, then soared by 58.49% to -$0.66 in 2024, then surged by 345.45% to $1.62 in 2025.
  • Business Quant data shows EPS (Basic) for ANAB at $1.62 in Q4 2025, $0.54 in Q3 2025, and -$1.34 in Q2 2025.